Back by Popular Demand - KRAS G12C Mutation: An Emerging Biomarker for NSCLC Sponsored by Amgen®
Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care: HHS/ASPR COVID-19 Therapeutics program
Myasthenia Gravis: How antibody testing helps you in the management of your patient
Give Us Your Feedback
Ion Mobility: Question and Answer Session with the Experts
Advanced Lipid Testing: Enabling a More Accurate Assessment of Cardiovascular Disease Risk
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
Low-Density Lipoprotein Particle Number Is Associated With Cardiovascular Events Among Those Not Classified Into Statin Benefit Groups.